Topotecan
- Licence status
- Withdrawn: 12/09/2017
- Active substances
- Topotecan hydrochloride
- Dosage Form
- Pdr/Conc/Soln for Infus
- Licence number
- PA1422/005/001
- Licence holder
- Fresenius Kabi Oncology Plc
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- L01XX Other antineoplastic agents, L01XX17 topotecan
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 28/01/2011